Source: Annual Congress 2005 - Gene expression, receptors and markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. S. Kim, S. J. Kim, S. Y. Lee, S. S. Kwon, Y. K. Kim, K. H. Kim, H. S. Moon, J. S. Song, S. H. Park, S. W. Moon, Y. P. Wang (Seoul, Republic Of Korea). Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC. Eur Respir J 2005; 26: Suppl. 49, 2931

Member's Comments

No comment yet.

Related content which might interest you: Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Expression of basic fibroblast growth factor (bFGF) in smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006 A role for vascular endothelial growth factor (VEGF) in fibrosis? Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Tissue levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase, vascular endothelial growth factor and cathepsin-D in patients with brochogenic cancer Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM). Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Source: Eur Respir J 2001; 17: 681-687 Year: 2001 Vascular endothelial growth factor (VEGF) isoform expression in primary human cultured alveolar epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003 Vascular endothelial growth factor (VEGF) and CD31 expression in experimental prosthetic tracheal replacement Source: Annual Congress 2009 - Current challenges in thoracic surgery Year: 2009 Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts Source: Eur Respir J 2003; 22: Suppl. 45, 7s Year: 2003 Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002 Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003 Vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt-1, VEGF-R2-KDR/Flk-1) as prognostic indicators in small cell lung carcinomas (SCLC) Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Up-regulation of vascular endothelial growth factor by placentagrowth factor via a post-transcriptional mechanism Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007